Entries by Ayal Ronen

Powered by CARB-X

Tyler Merkeley, CARB-X co-founder and program director for ASPR’s Biomedical Advanced Research and Development Authority, describes the drivers and next steps in creating a diverse portfolio Powered by CARB-X, one of the world’s largest public-private partnerships dedicated to accelerating development of innovative antibacterial drugs, diagnostics, and devices.      

Investment for Advanced Therapies – May 3, 2017

FreeMind is proud to support the upcoming Investment for Advanced Therapies event! When: May 3, 2017 Where: London, UK Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your […]

MedFIT – Fostering Innovation in medTech

FreeMind is pleased to support the upcoming MedFIT event!   Where: Grenoble, France When: June 28-29, 2017   A 360° approach to build innovation partnerships, source licensing deals and accelerate market access in medtech.   Organised by Eurasanté and the NHL Cluster, with the support of Medicalps and Alsace BioValley, the 1st edition of MedFIT will gather […]

BioTrinity 2017

The FreeMind Group is proud to support the upcoming BioTrinity conference! Where: London, UK When: May 8-10, 2017 BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK. Now in its 11th year, the aim of BioTrinity is simple – create an ideal networking and partnering platform for life science companies […]